anti-Claudin 18.2 CAR-T cell therapy / First Affiliated Hospital Xi'an Jiaotong University, Legend Biotech - LARVOL DELTA

A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma (clinicaltrials.gov) - P1; N=2; Terminated; Sponsor: First Affiliated Hospital Xi'an Jiaotong University; N=18 ➔ 2; Trial completion date: Dec 2023 ➔ Mar 2020; Recruiting ➔ Terminated; Trial primary completion date: Mar 2023 ➔ Mar 2020; the Preliminary data, progress of this study and the adjustment of the pipeline and strategy .

CAR T-Cell Therapy • Clinical • Enrollment change • IO Biomarker • Trial completion date • Trial primary completion date • Trial termination • Gastric Adenocarcinoma • Gastric Cancer • Gastroesophageal Junction Adenocarcinoma • Gastrointestinal Cancer • Oncology • Pancreatic Cancer • Pancreatic Ductal Adenocarcinoma • Solid Tumor • CXCL8 • IL2 • IL6